NDC 71209-048
VERAPAMIL HYDROCHLORIDE
Verapamil Hydrochloride
VERAPAMIL HYDROCHLORIDE is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Cadila Pharmaceuticals Limited. The primary component is Verapamil Hydrochloride.
Product ID | 71209-048_06026f05-9422-48af-89b8-803ae1a552e4 |
NDC | 71209-048 |
Product Type | Human Prescription Drug |
Proprietary Name | VERAPAMIL HYDROCHLORIDE |
Generic Name | Verapamil Hydrochloride |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2017-05-27 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA206173 |
Labeler Name | Cadila Pharmaceuticals Limited |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Active Ingredient Strength | 240 mg/1 |
Pharm Classes | P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |